Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2010

p38δ
p38 mitogen-activated protein kinase regulates skin
homeostasis and tumorigenesis
Tatiana Efimova
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Efimova, Tatiana, ,"p38δ mitogen-activated protein kinase regulates skin homeostasis and tumorigenesis."
Cell Cycle. 9,3. 498-505. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/2790

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

review

Cell Cycle 9:3, 498-505; February 1, 2010; © 2010 Landes Bioscience

p38δ mitogen-activated protein kinase regulates skin
homeostasis and tumorigenesis
Tatiana Efimova
Division of Dermatology; Department of Internal Medicine; Washington University School of Medicine; St. Louis, MO USA

Key words: p38δ signaling, keratinocyte, multistage chemical skin carcinogenesis, knockout mice, epidermis
Abbreviations: MAPK, mitogen-activated protein kinase; JNK, c-Jun NH2-terminal kinase; MK2, MAPK-activated protein kinase
2; DUSP, dual specificity phosphatase; LPS, lipopolysaccharide; TORC1, target of rapamycin complex 1; HNSCC, head and neck
squamous cell carcinoma; CC, cholangiocarcinoma; PKC, protein kinase C; DMBA, 7,12-dimethylbenz(a)anthracene; TPA, 12O-tetradecanoylphorbol-13-acetate

The p38δ mitogen-activated protein kinase (MAPK) is abundantly expressed in a wide array of tissues where it is likely
to have specific functions. This review aims to highlight recent
new insights into the biological roles of this relatively less studied p38 isoform. We focus on function of p38δ in regulating
of epidermal keratinocyte differentiation, apoptosis and skin
tumor development.

Introduction
The mitogen-activated protein kinases (MAPKs), including
extracellular signal-regulated protein kinases (ERKs), c-Jun
NH2-terminal kinases (JNKs) and p38, are evolutionary conserved families of serine/threonine kinases that control diverse
cellular processes in response to a variety of extracellular stimuli (reviewed in refs. 1 and 2). MAPK activity is regulated by
a three-module kinase cascade that include a MAPK, a MAPK
kinase (MAP2K, MKK or MEK) and a MAPK kinase kinase
(MAP3K, MAPKKK or MEKK).1,2 Activated MAPKs phosphorylate numerous downstream substrates, such as transcription
factors, protein kinases, cytoskeletal proteins and other targets.
The mammalian p38 MAPK family includes p38α, p38β, p38γ
and p38δ isoforms, encoded by MAPK14, MAPK11, MAPK12
and MAPK13 genes, respectively (reviewed in refs. 3 and 4). The
p38 family members are activated by environmental stresses,
inflammatory cytokines and growth factors. p38 MAPKs regulate a plethora of cellular responses including inflammation,
proliferation, differentiation, development, cell cycle control,
apoptosis, migration, senescence and tumorigenesis.3,4 Dual
specificity MAP2Ks MEK3 and MEK6 are the predominant
immediate upstream activators of p38s that phosphorylate threonine-180 and tyrosine-182 residues within the activation loops
of p38 isoforms. Additionally, MEK4- and MEK7-dependent, as
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well as MEK-independent activation of p38 has been reported
(reviewed in refs. 2–4). The MAP3Ks known to participate in
p38 activation include MEKK1-4, ASK1, TAK1, TAOs, MLK3.
Low molecular weight GTP-binding proteins of the Rho family,
including Rac1 and Cdc42, and p21-activated kinases (PAKs) are
among further upstream activators of p38 signaling.2-4 The physiological impact of the p38 MAPK activation is cell type- and
stimulus-dependent, and the specific functions of the individual
p38 isoforms under homeostatic and pathological conditions are
not well defined. p38 isoforms are dissimilar in their pattern of
expression, substrate specificities and sensitivity to pyridinyl imidazole inhibitors.3,4 p38α and p38β isoforms are ubiquitously
expressed and are susceptible to inhibition by pyridinyl imidazoles, such as SB203580. p38γ is highly expressed in skeletal muscle. p38δ is abundant in many tissues, including skin, pancreas,
testes, prostate gland, adrenal gland, small intestine, stomach,
colon, kidney and lung.5-9 p38γ and p38δ isoforms are insensitive to the pyridinyl imidazole compounds. Protein kinases MK2
and MK3 exemplify substrates preferentially phosphorylated by
p38α and p38β rather than p38γ and p38δ, while microtubuleassociated protein Tau appears to be a better substrate for p38γ
and p38δ than for p38α and p38β isoforms in transfected cells.3,4
These observations suggest highly specialized cellular functions
for individual p38 isoforms. p38α gene ablation in mice resulted
in early embryonic lethality due to placental and vascular abnormalities.10-13 p38β, p38γ, p38δ and double p38γ/p38δ knockout mice are viable and fertile, and exhibit no apparent health
problems.14,15 Currently, p38α, often referred to as p38, is by far
the best characterized isoform among p38 family members. In
contrast, considerably less attention has been focused on p38δ.
Here we intend to review the progress toward understanding the
functions of the p38δ signaling in physiological and pathophysiological settings, focusing, in particular, on its roles in epidermal
keratinocytes and in epithelial carcinogenesis.
Properties of p38δ
Regulation of p38δ activity. p38δ (also called SAPK4) was
cloned and characterized as the fourth member of the p38
MAPK that is 61, 59 and 65% identical to p38α, p38β and p38γ,
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respectively.5-8,16 The human p38δ/MAPK13 gene is located
on chromosome 6 and encodes a protein of 365 amino acids.7
The expression of p38δ is regulated in different developmental
stages in the mouse embryo, suggesting that p38δ is a developmentally regulated MAPK.7 Similar to the other p38 isoforms,
p38δ is robustly activated by inflammatory cytokines (i.e.,
TNFα, IL-1β) and environmental stresses (such as UV radiation, hyperosmotic shock, oxidative stress, arsenite), and to a
lesser degree by mitogenic stimuli. MAP2Ks reported to activate
p38δ include MEK3, MEK6, MEK4 and MEK7.6,7,17 The activation loop (T-loop) of p38δ contributes to the specificity of activation by MEK3.18 MEK3 deficiency has been shown to abrogate
the endogenous p38δ activation in response to TGFβ1 in murine
glomerular mesangial cells, suggesting a critical role for MEK3 as
an upstream activator of p38δ in this system.19 Of note, p38δ is
activated in a glomerulonephritis disease model in rat, suggesting
a possible involvement in the pathogenesis of this disease.6 The
MLK3/MEK7/p38δ signaling module scaffolded by an adaptor
protein islet brain-2 (IB2) has been described in cultured neuronal
cells.20 Future studies using MAP2K and MAP3K gene knockout
and RNAi-mediated knockdown approaches will define the specific contributions of individual upstream kinases in regulation
of p38δ activity in response to a given stimulus.
Intrinsically active mutants of all p38 isoforms have been
recently developed and demonstrated to maintain substrate
specificity and sensitivity to inhibitors of the parental native
p38s.21 Active mutants of p38, including p38δ mutant generated
by substituting phenylalanine-324 with serine (F324S), acquire
strong autophosphorylation capabilities that may emulate a natural mechanism of p38 activation. Autophosphorylation activity
results from conformational changes conferred by activating
mutations that are located in the L16 loop region of each isoform. Notably, the L16 loop of p38δ is purported to undergo
changes via regulatory mechanisms other than phosphorylation,
for instance, through interaction with other proteins.21
A dual-specificity phosphatase MAPK phosphatase 1 (MKP-1,
also known as DUSP1) has been implicated in downregulation
of hypertonicity-induced activation of both p38δ and p38α in
HEK293FT cell line.22 In contrast, MKP-1 fails to bind to and
inactivate p38δ in NIH3T3 cell line, and, similar to MKP-5
(also known as DUSP10) and MKP-7 (also known as DUSP16),
preferentially acts on p38α and p38β isoforms in this setting.23
The involvement of protein serine/threonine phosphatases PP1
and PP2A in downregulation of endogenous p38δ activity is suggested by finding that PP1/PP2A inhibitor okadaic acid (OA)
markedly increases p38δ activity in human epidermal keratinocytes.9,24 Interestingly, the endogenous p38δ is found in a
monophosphorylated, tyrosine-182-phosphorylated, form in
macrophages after LPS treatment.25 Upon treatment with LPS
and calyculin A, another inhibitor of PP1 and PP2A, p38δ activity is increased 25-fold versus LPS alone-treated cells, suggesting
that threonine-180 may be efficiently dephosphorylated by the
calyculin A-sensitive phosphatase(s) in this system.
p38δ substrates. Stathmin, a regulator of microtubule dynamics, has been identified as p38δ substrate both in vitro and in transfected cells, suggesting a potential role for p38δ in cytoskeletal
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remodeling.26 It is hypothesized that p38δ phosphorylates stathmin in times of stress, which would, in conjuction with phosphorylation by other kinases, enhance microtubule polymerization
to increase cell survival under stress. A microtubule-associated
protein Tau has been found to be a good substrate for p38δ and
p38γ in transfected COS cells.27,28 Using RNAi approach, p38δ
has been shown to be the major in vivo kinase that phosphorylates endogenous Tau at threonine-50 following osmotic shock of
neuroblastoma cells.29 Notably, phosphorylation of Tau at threonine-50 is suggested to be an early event after p38δ activation.
This phosphorylation promotes microtubule assembly and may
play a role in the adaptation of neurons to changes in osmolarity,
while subsequent hyperphosphorylation of Tau at additional sites
by p38δ and/or other kinases may negatively regulate the ability
of Tau to interact with microtubules and destabilize the microtubule network.29
p38δ phosphorylates and inactivates eukaryotic elongation factor 2 kinase (eEF2K), which causes dephosphorylation
and activation of eEF2K substrate eEF2 in response to cellular
stress induced by anisomysin, an agent that activates all stressactivated protein kinases, including p38δ.30 Furthermore, the
anisomysin-induced phosphorylation of eEF2K at serine-259 in
HEK293 cells is prevented by overexpression of a catalytically
inactive mutant of p38δ, and is unaffected by SB203580, U0126
or rapamycin, compounds that specifically inhibit p38α/p38β,
MEK1 and TORC1, respectively. These data suggest that p38δ
may mediate the inhibition of eEF2K and the resulting activation
of eEF2, to stimulate the translation of mRNAs encoding proteins whose levels are increased by stress. Fibroblast growth factor homologous factors (FHFs) are IB2-interacting proteins that
purportedly function in facilitating the assembly of the MLK3/
MEK7/p38δ complex scaffolded by IB2 in neurons.20 FHF1 has
been shown to serve as a p38δ substrate in transfected HEK293T
cells treated with hydrogen peroxide.20 A transcription factor
c-myb is phosphorylated by p38δ and, to a lesser degree, by
p38γ, in response to anisomysin-induced stress in transfected
HEK293 cells, leading to c-myc degradation via a proteasomedependent pathway.31 This regulation may have implications in
hematopoietic cell development, inflammatory responses and
cellular transformation. siRNA-mediated knockdown of p38δ
enhances hypertonicity-induced transcriptional activation of
the osmoprotective transcription factor TonEBP/OREBP, while
overexpresson of p38δ reduces it.22 Notably, p38α is shown to
have an opposite effect on the activity of this transcription factor. The physiological implications of the differential effects
of p38δ and p38α isoforms on TonEBP/OREBP are presently
being investigated.22 PKD1 has been identified as a target of p38δ
during regulation of insulin exocytosis.32 PKD1 has been found
to associate with ectopically expressed activated mutant form of
p38δ (p38δF324S) in HEK293T cells and in pancreatic β cell line.
Phosphorylation of PKD1 by p38δ negatively regulates PKD1
activity. Moreover, PKD1 activity is enhanced in pancreatic β
cells lacking p38δ, contributing to increased stimulated insulin
secretion and enhanced glucose tolerance observed in p38δ-null
mice.32 p38δ deficiency is shown to be protective against high
fat diet-induced insulin resistance and oxidative stress-stimulated
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pancreatic β cell failure. These findings suggest a pivotal role for
p38δ-PKD1 signaling module in regulation of pancreatic β cell
function in diabetic conditions.32
The Role of p38δ in Regulation of Keratinocyte
Function
The function of p38δ in keratinocyte differentiation. Epidermis,
the outermost layer of the skin, is a stratified squamous epithelium
that possesses a remarkable regenerating capacity and provides
a protective barrier against environmental assaults, dehydration
and loss of nutrients. To accomplish this critical life-sustaining
function, keratinocytes, the major cell type of the epidermis,
undergo a tightly regulated terminal differentiation program,
also known as cornification (reviewed in refs. 33–38). During
this process, mitotically active keratinocytes of the innermost
basal layer withdraw from the cell cycle, detach from the underlying basement membrane, and progressively differentiate to form
spinous, granular and cornified epidermal layers, as they ascend
toward the skin surface to ultimately develop into squames, dead
flattened anucleated cornified cells.33,34 These terminally differentiated squamous cells are composed of keratin microfibrils
surrounded by highly crosslinked insoluble proteinaceous structures referred to as cornified envelopes, which replace the plasma
membranes of differentiating keratinocytes. Specialized lipids
are extruded into the intercellular space between squames and
become covalently attached to the proteins of the cornified envelope. Together, the cornified envelope and extracellular lipids are
essential for effective physical and water barrier function in the
skin.35 Squamous cells are eventually sloughed off the skin surface
and are replaced by differentiating cells from the layers below. In
healthy epidermis, normal epidermal homeostasis is maintained
by a precisely controlled balance of proliferation, differentiation
and death.33,34,36,37 Malfunctions in control of this balance lead to
a compromised epidermal barrier function and result in development of dermatological diseases, including skin cancer, psoriasis,
disorders of keratinization and anomalous wound healing. The
molecular mechanisms underlying epidermal growth and differentiation control remain incompletely understood. A number
of signaling pathways implicated in regulation of keratinocyte
differentiation and skin barrier function has been identified in
recent years (reviewed in refs. 33, 34, 36 and 37), including
MAPK/SAPK cascades.
We used involucrin gene as a model to study the signaling
mechanisms that govern epidermal gene expression during keratinocyte differentiation.38-40 Involucrin is a component of the
cornified envelope that is crosslinked to various other structural
proteins during early stages in the envelope assembly, and provides a scaffold to which other envelope precursors are subsequently crosslinked.35,38,39 Involucrin is a marker of keratinocyte
terminal differentiation that is expressed in the spinous and the
granular, but not in the basal, epidermal layers. The investigation
of involucrin gene regulation has revealed important mechanisms
whereby intracellular signaling pathways and the downstream
transcription factors regulate differentiation-dependent epidermal gene expression (reviewed in ref. 39), and, in particular, has
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offered initial insights regarding the role of p38δ in epidermis
(reviewed in ref. 40).
A robust p38δ expression is detected in developing mouse
epidermis,7 as well as in neonatal and adult mouse and human
epidermis,9,41 suggesting a physiological function for p38δ in epidermal tissue. p38δ is expressed in both proliferating and nonproliferating epidermal layers.9,41 Notably, p38α and p38δ are the
predominant p38 MAPK isoforms expressed in normal keratinocytes, while p38β is detected at lower levels, and p38γ is virtually
undetectable.42,43 We found that p38δ is the major p38 isoform
activated in cultured normal human epidermal keratinocytes by
treatment with various differentiation-inducing agents, including 12-O-tetradecanoylphorbol-13-acetate (TPA), calcium, OA
and green tea polyphenol.9,44 Treatment of cultured keratinocytes with these and other differentiation-promoting agents is
known to induce morphological and biochemical changes, which
resemble those taking place during epidermal differentiation in
vivo, such as growth arrest and expression of terminal differentiation markers, including involucrin expression. Cell culture
and transgenic mouse studies show that the human involucrin
(hINV) gene upstream regulatory region, containing functional
activator protein 1 (AP1), CCAAT enhancer binding protein (C/
EBP), and Sp1 transcription factor binding sites, is essential for
differentiation-appropriate hINV gene expression both in vitro
and in vivo (reviewed in ref. 39). We have shown that differentiating agent-mediated endogenous p38δ activation correlates
with increased levels of hINV promoter activity, and endogenous
hINV mRNA and protein expression, as well as increased protein levels and enhanced binding of AP1 and C/EBP factors to
the hINV promoter, in cultured human keratinocytes undergoing differentiation.9,44,45 These responses are maintained in the
presence of SB203580, indicating the lack of involvement of the
inhibitor-sensitive p38α and/or p38β isoforms. On the other
hand, the differentiation-dependent increase in hINV promoter
activity is inhibited by a dominant-negative mutant of p38α,
which is expected to block activation of all p38 isoforms as it
binds to shared direct upstream p38 activators MEK3 and MEK6.
Moreover, the endogenous hINV protein levels are increased
in keratinocytes overexpressing p38δ, and further increased in
cells co-expressing both p38δ and PKCη, a differentiation-promoting isoform that activates p38δ signaling in keratinocytes.45
Altogether, these data suggest a role for p38δ isoform in activation of differentiation-dependent involucrin gene expression.
However, the induction of involucrin expression by treatment
with cholesterol-depleting agents involves p38α,46 and constitutively active MEK6 or MEK7, when overexpressed in keratinocytes, increase involucrin via a mechanism that involves p38α,42,47
suggesting that the engagement of a specific p38 isoform may be
stimulus-dependent. Interestingly, a genomic analysis has shown
that MAPK13 (a gene that encodes p38δ protein) and involucrin are among genes commonly upregulated both in psoriasis, a
benign inflammatory condition characterized by increased proliferation and differentiation, and in well-differentiated locally
invasive cutaneous squamous cell carcinomas (SCC).48 Moreover,
many additional genes encoding proteins involved in epidermal
differentiation are upregulated in both conditions, including
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keratinocyte transglutaminase, desmoglein 3, S100 proteins and
small proline-rich proteins. On the other hand, MAPK14 (a gene
that encodes p38α protein) is detected to be significantly upregulated in SCC only.48 Notably, invasion-associated matrix metalloproteinases (MMPs) 1 and 13 are also highly upregulated in
SCC only.48 In addition, MMP1 and MMP13 expression levels
are reduced by up to 90% by SB203580 in head and neck SCC
(HNSCC) cell lines, suggesting a key role for SB203580-sensitive
p38α in regulation of these enzymes (p38β expression in HNSCC
cells is minimal).43 Of note, increased kinase activities of p38α,
p38β and p38δ isoforms are detected in lesional compared with
nonlesional psoriatic skin.49 Altogether, these data support the
notion that p38 isoform-specific signaling may play distinct roles
in regulation of epidermal homeostasis and may differentially
contribute to the pathogenesis of various cutaneous pathologies,
possibly via responding to different stimuli, as well as by targeting distinct sets of substrates.
p38δ has been implicated in regulation of differentiation in
other cell systems, including primary human erythroid cells,50
intestinal epithelial cells51 and the myeloid lineage cells.25 Thus,
p38δ is expressed and active only during the terminal phase of
erythroid differentiation.50 Additionally, p38δ mRNA and protein expression are strikingly induced during blood monocyte
differentiation into macrophages.25 p38δ is expressed exclusively
in differentiated enterocytes, where it appears to be required for
execution of enterocyte anoikis.51
The function of p38δ in keratinocyte apoptosis. Our studies also show that p38δ has a role in regulation of keratinocyte
apoptosis.24,52 This dual role for p38δ in regulation of both epidermal terminal differentiation and apoptosis may not be surprising, considering that both processes are known to share some
common regulatory pathways.53 Our studies show that OA, a
potent inhibitor of serine/threonine protein phosphatases PP1
and PP2A, induces both differentiation- and apoptosis-associated
responses in keratinocytes. On the one hand, OA increases the
expression of involucrin, a marker of keratinocyte differentiation,9
while, on the other hand, it causes a disruption of mitochondrial
membrane potential, and caspase-dependent apoptosis.24 These
responses occur simultaneously in cultured keratinocytes, and
are associated with a selective, potent and sustained activation
of p38δ. What is more, p38α and p38β do not appear to contribute to any of these responses as they occur in an SB203580independent manner.9,24 In addition, overexpression of p38δ
enhances OA-induced apoptosis.24 These data indicate that p38δ
is a mediator of OA-stimulated apoptotic cell death in keratinocytes. Moreover, a co-expression of p38δ together with either an
activated form of its direct upstream activator MEK6, or its distal upstream activator PKCδ, causes apoptosis-like morphological changes in the absence of any additional external stimulus.52
These changes are similar to those elicited by OA exposure, and
are associated with loss of the mitochondrial membrane potential, cytochrome c release, and killer caspase activation, the typical features of apoptotic cell death. This death response is specific
for the combination of PKCδ and p38δ, and does not occur when
PKCδ is replaced with PKCα, or p38δ with p38α. In addition,
treatment of cells with SB203580 does not inhibit this response,
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further ruling out the role for p38α and/or p38β isoforms in this
process.52
PKCδ, a member of the novel PKC subfamily, has been
implicated in regulating both the differentiation and the apoptosis processes in epidermal keratinocytes.24,45,54-59 We found that
PKCδ potently activates both ectopically expressed and endogenous p38δ in keratinocytes.45 PKCη and PKCε are additional
members of the novel PKC subfamily that are expressed in keratinocytes.59 Paradoxically, while PKCη is also a potent activator of p38δ (a regulation associated with increased involucrin
expression), coupling of PKCη and p38δ fails to cause apoptosis
in this cell culture model.45,52 This is consistent with a reported
role for PKCη as a negative regulator of UVB-induced apoptosis
in normal human keratinocytes.60 In contrast, despite the fact
that PKCε has been implicated in promoting cell survival and
tumorigenesis,61 PKCε promotes apoptosis when coupled to p38δ
in our cell culture model.52 Additional studies are needed to elucidate the molecular basis underlying this diverse regulation.
Hydrogen peroxide (H2O2), a mediator of oxidative stress-induced cell death and a known inducer of keratinocyte apoptosis,
produces similar apoptotic morphological changes, and promotes
the endogenous PKCδ and p38δ activation, when added exogenously to cultured keratinocytes.52 The function of p38δ in
promoting oxidative stress-mediated apoptosis in vivo has been
substantiated by finding that p38δ deficient mice exhibited 5-fold
lower rates of pancreatic β cell apoptosis in response to treatment
with apoptosis-inducing agent streptozotocin.32
Interestingly, keratinocytes undergoing apoptosis in response
to various stimuli, such as H2O2 or OA exposure, or co-expression of PKCδ/p38δ, consistently display concurrent p38δ activation and ERK1/2 inactivation.9,24,52 We found that reduction in
ERK1/2 activity is essential for apoptosis, since forced ERK1/2
activation, by means of expressing constitutively active form of
MAP3K Raf1, a specific upstream activator of ERK1/2, inhibits
PKCδ/p38δ-induced apoptosis.52 These data suggest that a balance between prosurvival ERK1/2 signaling and proapoptotic/
prodifferentiation stress-activated protein kinase p38δ signaling
is a crucial determinant of cell fate decisions. We studied the
mechanisms of coordinated and inverse regulation of p38δ activation and ERK1/2 inactivation in keratinocytes. Our studies
reveal two important aspects of this regulation: the formation of
p38δ-ERK1/2 complex that is constitutively present in stimulated and nonstimulated keratinocytes, and translocation of the
complex from the cytoplasm into the nucleus upon stimulation
with PKCδ.9,52 This PKCδ-stimulated nuclear co-localization of
p38δ-ERK1/2 complex is sustained up to 48 hours after initiation of treatment, and is associated with maintenance of p38δ
activity and inactivation of ERK1/2. The latter may be carried
out by resident nuclear phosphatases that become activated in
response to nuclear accumulation of ERK1/2, as previously
reported.62 Moreover, the interaction of p38δ and ERK1/2 may
result in conformational changes in ERK1/2 that facilitate their
interactions with phosphatases. Additionally, activated p38δ may
act to retain unphosphorylated ERK1/2 in the nucleus, thus
preventing ERK1/2 re-localization into the cytoplasm where
the upstream ERK1/2 activator, MEK1, resides. Activated p38δ
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may contribute to proapoptotic phenotype by stimulating apoptosis-related transcriptional changes the specific nature of which
remains to be elucidated. Notably, a complex formation between
p38α splice variant, Mxi2 and ERK1/2 has been recently
reported.63,64 Mxi2 constitutively binds to ERK1/2 and promotes
stimulus-independent ERK1/2 nuclear import. Mxi2 promotes
nuclear accumulation of both phosphorylated and unphosphorylated forms of ERK1/2. The biological rationale underlying the
Mxi2 functions in nuclear shuttling of ERK1/2 remains to be
established. Mxi2 overexpression in certain renal tumors is associated with ERK1/2 redistribution which may contribute to disease.64 A physical interaction between p38γ isoform and ERK1/2
in K-Ras-transformed intestinal epithelial cells has been recently
reported.65 It is suggested that unphosphorylated p38γ may function to promote K-Ras transformation through an increased
complex formation with ERK1/2 proteins. A direct association
between p38α and ERK1/2 has also been described that leads to
ERK1/2 inhibition, purportedly via blocking MEK1-dependent
ERK1/2 phosphorylation.66 Overall, these findings, demonstrating the capacities of different p38 isoforms to physically interact
with ERK1/2 kinases and to modulate ERK1/2 activity and/or
subcellular distribution, highlight the potential functional significance of this regulatory mechanism in influencing cell fate
decisions in response to stress.
The function of p38δ in skin tumor development. Increased
expression of p38δ has been detected in human primary cutaneous SCCs,48 and increased activation of p38δ has been observed
in HNSCC cells in culture as well as in HNSCC tumors in
vivo.43 In addition, a recent study reports increased p38δ mRNA
and protein levels in cholangiocarcinoma (CC), an aggressive liver malignancy, and in liver cancer cell lines.67 p38δ has
been reported to regulate HNSCC and CC invasion.43,67 Taken
together, these findings suggest a potential role for p38δ in
human malignancies.
Our recent study has suggested that p38δ is required for the
development of skin tumors in the multistage chemical carcinogenesis model in mouse skin.41 In this well characterized model
(reviewed in refs. 68–72), during the initiation stage, a single
topical treatment with a chemical mutagen 7,12-dimethylbenz(a)
anthracene (DMBA) induces activating mutations in H-ras gene.
The population of mutated “initiated” cells undergoes clonal
expansion after repeated applications of a tumor promoting
agent, such as TPA, leading to development of benign tumors,
papillomas. Some of papillomas may spontaneously progress to
invasive SCCs. The conversion of papillomas to SCCs is associated with progressive chromosomal abnormalities that occur
independently of treatment with tumor promoting agents. As
the multistage skin carcinogenesis model in mice recapitulates
features of multistage carcinogenesis in humans, this model is
a useful experimental tool to study the mechanisms of human
epithelial carcinogenesis.68-72
Using the DMBA/TPA regimen, we found that p38δ knockout mice15 displayed a significantly reduced susceptibility to
the multistage chemical skin caricnogenesis.41 p38δ deficiency
resulted in a delay of tumor development and a significantly
reduced numbers and size of tumors compared with wild-type

502

mice. Decreased skin carcinogenesis in p38δ knockout mice
correlated with reduced epidermal proliferation during tumor
promotion with TPA. Interestingly, a major cancer promoting
cascade, ERK1/2-AP1 signaling pathway, showed reduced activation in TPA-treated p38δ-deficient epidermis. In this regard,
it is noteworthy that deletion of ERK1 has been shown to inhibit
DMBA/TPA-induced mouse skin carcinogenesis.73 In addition,
the epidermal-specific expression of dominant-negative AP1
transgene led to a marked resistance to chemical skin carcinogenesis.74 Furthermore, a repressed ERK1/2-AP1 signaling correlated
with reduced DMBA/TPA-stimulated skin tumor development
in JNK2 knockout mice,75 while increased ERK1/2-AP1 signaling was associated with enhanced susceptibility to chemical skin
carcinogenesis in JNK1 knockout mice.76 These findings suggest
that a reduced proliferative response during tumor promotion
may limit intensive tumor growth and thus account for a marked
protection against chemical skin carcinogenesis commonly
observed in these mouse models.
We also found that p38δ-deficient mice exhibited markedly
reduced levels of activated signal transducer and activator of
transcription 3 (Stat3) oncogenic transcription factor in DMBA/
TPA-induced papillomas, in comparison with tumors derived
from their wild-type counterparts.41 This indicates that Stat3 is
a downstream target of p38δ-stimulated signaling in skin tumor
development. Studies using skin-specific gain and loss of function Stat3 transgenic mouse models have shown that Stat3 has
critical roles in both chemically and UVB-induced skin carcinogenesis.77 Stat3 is required for the survival of keratinocyte stem
cells during tumor initiation.78 In addition, Stat3 drives epithelial
proliferation necessary for clonal expansion of initiated cells.78
Finally, Stat3 is known to play a role in malignant conversion by
regulating a number of genes involved in angiogenesis and invasion.79 Our data argue that p38δ regulates Stat3 activation during epithelial carcinogenesis, suggesting that p38δ promotes skin
tumor development at least in part by regulating Stat3 signaling
pathway. The molecular mechanisms whereby this regulation is
executed remain to be elucidated.
p38δ knockout mice also displayed a markedly reduced susceptibility to lung tumorigenesis induced by oncogenic mutation of K-ras gene, including significantly decreased number
of tumors, average tumor volume and total tumor volume per
lung, compared with their wild type counterparts.41 In contrast,
p38α deletion resulted in hyperproliferation of lung epithelium,
and sensitized p38α-deficient mice to K-ras-induced lung tumor
development.80 These data suggest that p38δ and p38α isoforms
may have opposing functions in regulating oncogenic Ras-driven
lung carcinogenesis. However, both p38α and p38δ genes are
upregulated in human cutaneous SCCs,48 and kinase activity of
both isoforms is increased in HNSCCs.43 Moreover, both p38α
and p38δ are implicated in regulation of invasion and proliferation of HNSCC cells.43 Therefore, although the function for
p38α as a tumor suppressor in vivo has been demonstrated by
a plethora of studies using genetically engineered mouse models (reviewed in refs. 81–84), a notion that p38α signaling may
function to promote skin tumorigenesis needs to be explored in
future investigations.
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Figure 1. The involvement of p38δ in regulation of biological processes and disease conditions.

A significant protection against epithelial carcinogenesis
afforded by a germline p38δ deletion in mice41 may potentially
be mediated by specific and/or redundant contributions from
both epithelial and non-epithelial cell types. Development of
epithelial-derived tumors is known to be stimulated by inflammation, and inflammatory cells and mediators are present in the
microenvironment of all tumors in experimental animal models
and humans from the earliest stages of tumor development.84,85
In addition, activated oncogenic Ras signaling induces production of tumor-promoting inflammatory cytokines and chemokines, which contributes to the formation of tumor-promoting
microenvironment.85 Activation of p38 signaling is known to be
important for the production of tumor-promoting inflammatory
cytokines, such as TNFα, IL-1β and IL-6 (reviewed in refs. 3,
4 and 84). p38α and p38δ are the predominant p38 isoforms
expressed in immune (myeloid) cells.25 Interestingly, studies using
conditional knockout of p38α in macrophages show that p38α
is essential for production of some cytokines (such as TNFα and
IL-12), but not others (such as IL-6), in response to stimulation
with LPS.86 On the other hand, a recent report, using RNAi
approach, suggests that p38δ may have a role in regulation of
IL-6 biosynthesis.87 It is noteworthy that the mechanisms of constitutive Stat3 activation in many tumors include, among others,
both autocrine and paracrine production of IL-6 leading to Stat3
phosphorylation.88 It would be of interest to investigate whether
p38δ/IL-6/Stat3 signaling axis has a functional role in promoting epithelial carcinogenesis. Remarkably, analysis of the effect of
p38α ablation in myeloid and epidermal cells have revealed distinct cell type-specific functions of p38α signaling in regulation
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of inflammatory responses to various types of skin injury.89 For
example, epidermal p38α was required for acute inflammatory
responses to UVB-induced epidermal injury, whereas myeloid
p38α exerted anti-inflammatory regulation in acute UVB- and
TPA-induced skin responses via activation of anti-inflammatory
gene expression.89 Future studies using conditional epithelialand myeloid-cell-specific deletion of p38δ will identify cell typespecific effects of p38δ deficiency on epithelial inflammatory
responses and carcinogenesis, and will provide insights into the
underlying molecular processes.
Concluding Remarks
Recent studies using p38δ deficient mice have begun to contribute
to advancing our understanding of the in vivo roles of this enigmatic p38 isoform. Thus, p38δ knockout mice have been demonstrated to exhibit improved glucose tolerance due to enhanced
insulin secretion from pancreatic β cells.32 Moreover, these mice
are protected against high fat diet-mediated insulin resistance and
oxidative stress-induced β cell apoptosis. This study suggests that
p38δ is a potential therapeutic target for human diabetes.32 Our
recent studies using p38δ knockout mice have revealed essential in
vivo role of p38δ as a positive regulator of skin and lung tumorigenesis.41 Moreover, increased expression and/or activity of p38δ
are demonstrated in human malignancies, such as cutaneous SCC,
HNSCC and liver malignancy CC.43,48,67 These findings suggest
that targeting p38δ is a promising strategy for cancer therapy. Much
remains to be learned regarding the molecular mechanisms underlying p38δ function(s) in regulation of epithelial tumorigenesis.
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Genomic and proteomic approaches will assist in discovery of
specific p38δ-regulated genes and interacting protein partners.
Epidermal-specific inducible p38δ-deficient mice will need to be
generated and characterized to define the role of p38δ in each stage
of multistage chemical carcinogenesis in mouse skin.90 A potential
contribution of non-epithelial cell types (i.e., cells of myeloid lineage) to reduced tumor development in p38δ-null mice will need
to be addressed by generation of mouse models featuring cell-type
specific p38δ deletion, and subjecting these mice to multistage
chemical carcinogenesis regimen. Finally, it would be of interest
to examine the impact of p38δ deficiency on UVB-induced skin
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